These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38579614)
1. Ferroptosis inducers: A new frontier in cancer therapy. Ma W; Hu N; Xu W; Zhao L; Tian C; Kamei KI Bioorg Chem; 2024 May; 146():107331. PubMed ID: 38579614 [TBL] [Abstract][Full Text] [Related]
2. Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches. Luo Y; Bai XY; Zhang L; Hu QQ; Zhang N; Cheng JZ; Hou MZ; Liu XL Drug Des Devel Ther; 2024; 18():2485-2529. PubMed ID: 38919962 [TBL] [Abstract][Full Text] [Related]
3. Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy. Tang X; Niu Y; Jian J; Guo Y; Wang Y; Zhu Y; Liu B Crit Rev Oncol Hematol; 2024 Jan; 193():104203. PubMed ID: 37979734 [TBL] [Abstract][Full Text] [Related]
4. Recent Progress in Ferroptosis Inducers for Cancer Therapy. Liang C; Zhang X; Yang M; Dong X Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562 [TBL] [Abstract][Full Text] [Related]
5. Targeting Ferroptosis: Small-molecule Inducers as Novel Anticancer Agents. Jin S; Wang H; Zhang Z; Yan M Anticancer Agents Med Chem; 2024 Oct; ():. PubMed ID: 39411969 [TBL] [Abstract][Full Text] [Related]
6. BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells. Moujalled D; Southon AG; Saleh E; Brinkmann K; Ke F; Iliopoulos M; Cross RS; Jenkins MR; Nhu D; Wang Z; Shi MX; Kluck RM; Lessene G; Grabow S; Bush AI; Strasser A Cell Death Differ; 2022 Jul; 29(7):1335-1348. PubMed ID: 35332309 [TBL] [Abstract][Full Text] [Related]
7. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines. Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532 [TBL] [Abstract][Full Text] [Related]
8. Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance. D'Aprile S; Denaro S; Pavone AM; Giallongo S; Giallongo C; Distefano A; Salvatorelli L; Torrisi F; Giuffrida R; Forte S; Tibullo D; Li Volti G; Magro G; Vicario N; Parenti R J Transl Med; 2023 Nov; 21(1):780. PubMed ID: 37924062 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of ferroptosis and its role in cancer therapy. Xu T; Ding W; Ji X; Ao X; Liu Y; Yu W; Wang J J Cell Mol Med; 2019 Aug; 23(8):4900-4912. PubMed ID: 31232522 [TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-driven nanotherapeutics for cancer treatment. Shan X; Li S; Sun B; Chen Q; Sun J; He Z; Luo C J Control Release; 2020 Mar; 319():322-332. PubMed ID: 31917296 [TBL] [Abstract][Full Text] [Related]
11. Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1α signalling axis in liver cancer. Li YZ; Deng J; Zhang XD; Li DY; Su LX; Li S; Pan JM; Lu L; Ya JQ; Yang N; Zhou J; Yang LH Heliyon; 2024 Jun; 10(11):e32288. PubMed ID: 38912485 [TBL] [Abstract][Full Text] [Related]
12. Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis. Hu Q; Wei W; Wu D; Huang F; Li M; Li W; Yin J; Peng Y; Lu Y; Zhao Q; Liu L Front Cell Dev Biol; 2022; 10():810327. PubMed ID: 35223839 [TBL] [Abstract][Full Text] [Related]
13. Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects. Yu S; Tong L; Shen J; Li C; Hu Y; Feng K; Shao J Eur J Med Chem; 2024 Apr; 269():116290. PubMed ID: 38518522 [TBL] [Abstract][Full Text] [Related]
14. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Khan F; Pandey P; Verma M; Ramniwas S; Lee D; Moon S; Park MN; Upadhyay TK; Kim B Biomed Pharmacother; 2024 Apr; 173():116363. PubMed ID: 38479184 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer. Ghoochani A; Hsu EC; Aslan M; Rice MA; Nguyen HM; Brooks JD; Corey E; Paulmurugan R; Stoyanova T Cancer Res; 2021 Mar; 81(6):1583-1594. PubMed ID: 33483372 [TBL] [Abstract][Full Text] [Related]
16. Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment. Farzipour S; Zefrei FJ; Bahadorikhalili S; Alvandi M; Salari A; Shaghaghi Z Anticancer Agents Med Chem; 2024; 24(8):571-589. PubMed ID: 38275050 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940 [TBL] [Abstract][Full Text] [Related]
18. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment? Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962 [TBL] [Abstract][Full Text] [Related]
19. Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc Ning X; Qi H; Yuan Y; Li R; Wang Y; Lin Z; Yin Y Eur J Pharmacol; 2022 Nov; 934():175304. PubMed ID: 36174666 [TBL] [Abstract][Full Text] [Related]
20. Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute Leukemia. Kumada H; Itoh M; Tohda S Anticancer Res; 2024 Mar; 44(3):1003-1010. PubMed ID: 38423654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]